Medindia

X

Crdentia Appoints Debbie Griffith to Director of Business Development, Reporting Directly to CEO

Friday, January 11, 2008 General News J E 4
Advertisement
DALLAS, Jan. 10 Crdentia Corp.(OTC Bulletin Board: CRDT), a leading healthcare staffing company, todayannounced the appointment of Ms. Debbie Griffith, formerly Director ofOperations in Houston, Texas, to Director of Business Development. In thisnewly created position, Ms. Griffith will report directly to CEO, John Kaiserand will be responsible for ensuring that Crdentia branch offices adequatelyexpand their services to keep pace with healthcare staffing industry trendsthat show rapidly increasing demand for allied health and locum tenensstaffing.

"Debbie will play a critical role in assisting smaller Crdentia markets tobecome a single source, not only for quality nurses, but for healthcare staffof all professions and specialties. Her extensive experience staffing a largerange of healthcare professionals and proven ability to successfully diversifyrevenue sources will be a great asset to our branches," said John Kaiser, CEO.

Ms. Griffith joined Crdentia in July, 2007 and brought with her 16 yearsof experience gained from management and executive level positions at threelarge healthcare staffing companies in Houston, Texas, where she wasinstrumental in negotiating new client contracts, generating revenue streams,increasing recruitment, promoting performance improvements and diversifyingbusiness services.

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcarestaffing solutions, is focused on recruiting talented national andinternational healthcare professionals to meet the ever-increasing employmentneeds of over 2,300 clients. Crdentia is one of the few companies that canprovide quality temporary staff for all healthcare industry positionsincluding local nurses, travel nurses, allied health, locum tenens and homecare professionals. For more information, visit http://www.crdentia.com.

Forward Looking Statements

Statements contained in this release that are not historical facts areforward-looking statements that involve risks and uncertainties. Among theimportant factors which could cause actual results to differ materially fromthose in the forward-looking statements include, but are not limited to, thosediscussed in "Risk Factors" in the Company's Forms 10-K, Forms 10-Q, and otherfilings with the Securities and Exchange Commission. Such risk factorsinclude, but are not limited to, a limited operating history with no earnings;reliance on the Company's management team; the ability to successfullyimplement the Company's business plan; the ability to continue as a goingconcern; the ability to fund the Company's business and acquisition strategy;the growth of the temporary healthcare professional staffing business;difficulty in managing operations of acquired businesses; uncertainty ingovernment regulation of the healthcare industry; and limited trading in thepublic market for the Company's common stock. The actual results that theCompany achieves may differ materially from any forward-looking statements dueto such risks and uncertainties. We undertake no obligation to revise orupdate publicly any forward-looking statements for any reason.Contact Crdentia Corp. John Kaiser, CEO Phone: 972.850.0780 Fax: 972.392.2722 jkaiser@crdentia.com Jim TerBeest, CFO Phone: 972.850.0780 Fax: 972.392.2722 jterbeest@crdentia.com

SOURCE Crdentia Corp.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Transgene's Therapeutic Vaccine TG4010 Shows Promi...
S
Tethys Bioscience Hits Key Milestones With Series ...